Hollis P H, Zappulla R A, Spigelman M K, Feuer E J, Holland J F, Malis L I
Department of Neurosurgery, Mount Sinai Medical School, New York, New York 10029.
Exp Neurol. 1988 Feb;99(2):428-39. doi: 10.1016/0014-4886(88)90159-8.
This study investigated the effects of hypertension and water loading on etoposide-induced, reversible blood-brain barrier disruption in a rat model. Twenty-nine animals were divided into four groups: group 1--intracarotid (i.c.) injection of saline followed in 1 h by 5 ml i.c. water; group 2--i.c. etoposide followed by i.c. water; group 3--i.c. saline followed by i.v. metaraminol to increase systemic blood pressure; group 4--i.c. etoposide followed by i.v. metaraminol. Systemic blood pressure and intracranial pressure were monitored continuously. Evans blue staining of the brain was used as a monitor of blood-brain barrier disruption. Animals were killed 1 h after either aramine or water infusion, and the brains removed and inspected for the degree of disruption. After dehydration, brain water was calculated for each hemisphere. Two-thirds of the animals infused with etoposide had evidence of barrier disruption, whereas none of the control animals infused with saline were disrupted. Neither control groups 1 or 3 showed significant change in intracranial pressure after water loading or augmentation of systemic blood pressure, respectively. Group 4 animals failed to demonstrate any significant change in intracranial pressure despite marked barrier disruption and acute hypertension (within the limits of normal autoregulation). A small but statistically significant increase in intracranial pressure was noted in group 2 animals with the greatest degree of barrier disruption. A significant increase in brain water was observed ipsilateral to etoposide infusion in only those animals with the most marked barrier disruption. These results indicate that etoposide-induced blood-brain barrier disruption caused significant increases in brain water without significant alteration of cerebral vasomotor tone or increases in intracranial pressure after water loading except in the most severe disruption. The classic untoward consequences of vasogenic edema were not encountered in the present model.
本研究在大鼠模型中探究了高血压和水负荷对依托泊苷诱导的、可逆性血脑屏障破坏的影响。29只动物被分为四组:第1组——颈内注射生理盐水,1小时后颈内注射5毫升水;第2组——颈内注射依托泊苷,随后颈内注射水;第3组——颈内注射生理盐水,随后静脉注射间羟胺以升高全身血压;第4组——颈内注射依托泊苷,随后静脉注射间羟胺。持续监测全身血压和颅内压。大脑伊文思蓝染色用于监测血脑屏障破坏情况。在注入间羟胺或水1小时后处死动物,取出大脑并检查破坏程度。脱水后,计算每个半球的脑含水量。三分之二注入依托泊苷的动物有血脑屏障破坏的证据,而注入生理盐水的对照组动物均未出现屏障破坏。对照组1或3在水负荷或全身血压升高后,颅内压均未出现显著变化。第4组动物尽管血脑屏障有明显破坏且出现急性高血压(在正常自动调节范围内),但颅内压未出现任何显著变化。屏障破坏程度最大的第2组动物颅内压有小幅但具有统计学意义的升高。仅在那些屏障破坏最明显的动物中,观察到依托泊苷注入侧的脑含水量显著增加。这些结果表明,依托泊苷诱导的血脑屏障破坏导致脑含水量显著增加,除了最严重的破坏情况外,在水负荷后脑血管运动张力无显著改变,颅内压也未升高。在本模型中未出现血管源性水肿的典型不良后果。